Filamin A expression correlates with proliferation and invasive properties of human metastatic melanoma tumors: implications for survival in patients

Journal of Cancer Research and Clinical Oncology

Volumn 140, Issue 11, 2014, Pages 1913-1926

  Zhang, Kai ^a   Zhu, Tienian ^a,b   Gao, Dongmei ^b   Zhang, Yimei ^b   Zhao, Qinglan ^b   Liu, Shuang ^b   Su, Tongyi ^b   Bernier, Michel ^c   Zhao, Ruijing ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b BETHUNE INTERNATIONAL PEACE HOSPITAL   (China)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

EGFR; FLNa; Malignant melanoma; Metastasis; Proliferation

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FILAMIN A; EGFR PROTEIN, HUMAN; FILAMIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELL DENSITY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CLINICAL ARTICLE; CLONOGENIC ASSAY; COLONY FORMATION; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MELANOMA CELL LINE; METASTATIC MELANOMA; MOUSE; MTT ASSAY; NONHUMAN; OVERALL SURVIVAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TUMOR INVASION; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CELL MOTION; KAPLAN MEIER METHOD; MELANOMA; METABOLISM; MORTALITY; NUDE MOUSE; PATHOLOGY; PHOSPHORYLATION; PROTEIN PROCESSING; SECONDARY; SKIN TUMOR; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; FILAMINS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MELANOMA; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR, EPIDERMAL GROWTH FACTOR; SKIN NEOPLASMS; TUMOR BURDEN;

EID: 84919481599     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1722-3     Document Type: Article

References (49)

1. Alper O, Stetler-Stevenson WG, Harris LN, Leitner WW, Ozdemirli M, Hartmann D, Raffeld M, Abu-Asab M, Byers S, Zhuang Z, Oldfield EH, Tong Y, Bergmann-Leitner E, Criss WE, Nagasaki K, Mok SC, Cramer DW, Karaveli FS, Goldbach-Mansky R, Leo P, Stromberg K, Weil RJ (2009) Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma. Cancer Sci 100(9):1748–1756. doi:10.1111/j.1349-7006.2009.01244.x
2. Avraham R, Yarden Y (2011) Feedback regulation of EGFR signaling: decision making by early and delayed loops. Nat Rev Mol Cell Biol 12(2):104–117. doi:10.1038/nrm3048
3. Barriere H, Nemes C, Du K, Lukacs GL (2007) Plasticity of polyubiquitin recognition as lysosomal targeting signals by the endosomal sorting machinery. Mol Biol Cell 18(10):3952–3965. doi:10.1091/mbc.E07-07-0678
4. Baselga J, Albanell J (2002) Epithelial growth factor receptor interacting agents. Hematol/Oncol Clin N Am 16(5):1041–1063
5. Bedolla RG, Wang Y, Asuncion A, Chamie K, Siddiqui S, Mudryj MM, Prihoda TJ, Siddiqui J, Chinnaiyan AM, Mehra R, de Vere White RW, Ghosh PM (2009) Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases. Clin Cancer Res 15(3):788–796. doi:10.1158/1078-0432.CCR-08-1402
6. Bullock MD, Sayan AE, Packham GK, Mirnezami AH (2012) MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression. Biol Cell 104(1):3–12. doi:10.1111/boc.201100115
7. Cano CE, Motoo Y, Iovanna JL (2010) Epithelial-to-mesenchymal transition in pancreatic adenocarcinoma. Sci World J 10:1947–1957. doi:10.1100/tsw.2010.183
8. Citri A, Yarden Y (2006) EGF–ERBB signaling: towards the systems level. Nat Rev Mol Cell Biol 7(7):505–516. doi:10.1038/nrm1962
9. Cock-Rada A, Weitzman JB (2013) The methylation landscape of tumour metastasis. Biol Cell 105(2):73–90. doi:10.1111/boc.201200029
10. Djinovic-Carugo K, Carugo O (2010) Structural portrait of filamin interaction mechanisms. Cur Protein Pept Sci 11(7):639–650
11. Eggermont AM, Spatz A, Robert C (2014) Cutaneous melanoma. Lancet 383(9919):816–827. doi:10.1016/S0140-6736(13)60802-8
12. Fernandez-Flores A (2012) Prognostic factors for melanoma progression and metastasis: from Hematoxylin–Eosin to genetics. Rom J Morphol Embryol 53(3):449–459
13. Fiori JL, Zhu TN, O’Connell MP, Hoek KS, Indig FE, Frank BP, Morris C, Kole S, Hasskamp J, Elias G, Weeraratna AT, Bernier M (2009) Filamin A modulates kinase activation and intracellular trafficking of epidermal growth factor receptors in human melanoma cells. Endocrinology 150(6):2551–2560. doi:10.1210/en.2008-1344
14. Flanagan MB, Dabbs DJ, Brufsky AM, Beriwal S, Bhargava R (2008) Histopathologic variables predict Oncotype DX recurrence score. Mod Pathol 21(10):1255–1261. doi:10.1038/modpathol.2008.54
15. Flevaris P, Stojanovic A, Gong H, Chishti A, Welch E, Du X (2007) A molecular switch that controls cell spreading and retraction. J Cell Biol 179(3):553–565. doi:10.1083/jcb.200703185
16. Grandal MV, Madshus IH (2008) Epidermal growth factor receptor and cancer: control of oncogenic signaling by endocytosis. J Cell Mol Med 12(5A):1527–1534. doi:10.1111/j.1582-4934.2008.00298.x
17. Grovdal LM, Stang E, Sorkin A, Madshus IH (2004) Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation. Exp Cell Res 300(2):388–395. doi:10.1016/j.yexcr.2004.07.003
18. Grunewald TG, Herbst SM, Heinze J, Burdach S (2011) Understanding tumor heterogeneity as functional compartments—superorganisms revisited. J Trans Med 9:79. doi:10.1186/1479-5876-9-79
19. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674. doi:10.1016/j.cell.2011.02.013
20. He HJ, Zhu TN, Xie Y, Fan J, Kole S, Saxena S, Bernier M (2006) Pyrrolidine dithiocarbamate inhibits interleukin-6 signaling through impaired STAT3 activation and association with transcriptional coactivators in hepatocytes. J Biol Chem 281(42):31369–31379. doi:10.1074/jbc.M603762200
21. Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat JP, Nickerson E, Auclair D, Li L, Place C, Dicara D, Ramos AH, Lawrence MS, Cibulskis K, Sivachenko A, Voet D, Saksena G, Stransky N, Onofrio RC, Winckler W, Ardlie K, Wagle N, Wargo J, Chong K, Morton DL, Stemke-Hale K, Chen G, Noble M, Meyerson M, Ladbury JE, Davies MA, Gershenwald JE, Wagner SN, Hoon DS, Schadendorf D, Lander ES, Gabriel SB, Getz G, Garraway LA, Chin L (2012) A landscape of driver mutations in melanoma. Cell 150(2):251–263. doi:10.1016/j.cell.2012.06.024
22. Hynes NE, MacDonald G (2009) ErbB receptors and signaling pathways in cancer. Curr Opin Cell Biol 21(2):177–184. doi:10.1016/j.ceb.2008.12.010
23. Jiang X, Yue J, Lu H, Campbell N, Yang Q, Lan S, Haffty BG, Yuan C, Shen Z (2013) Inhibition of filamin-A reduces cancer metastatic potential. Int J Biol Sci 9(1):67–77. doi:10.7150/ijbs.5577
24. Kim EK, Choi EJ (2010) Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta 1802(4):396–405. doi:10.1016/j.bbadis.2009.12.009
25. Kim H, McCulloch CA (2011) Filamin A mediates interactions between cytoskeletal proteins that control cell adhesion. FEBS Lett 585(1):18–22. doi:10.1016/j.febslet.2010.11.033
26. Kim H, Nakamura F, Lee W, Hong C, Perez-Sala D, McCulloch CA (2010) Regulation of cell adhesion to collagen via beta1 integrins is dependent on interactions of filamin A with vimentin and protein kinase C epsilon. Exp Cell Res 316(11):1829–1844. doi:10.1016/j.yexcr.2010.02.007
27. Kim Y, Stolarska MA, Othmer HG (2011) The role of the microenvironment in tumor growth and invasion. Prog Biophys Mol Biol 106(2):353–379. doi:10.1016/j.pbiomolbio.2011.06.006
28. Kunz M (2014) Oncogenes in melanoma: an update. Eur J Cell Biol 93(1–2):1–10. doi:10.1016/j.ejcb.2013.12.002
29. Kyndt F, Gueffet JP, Probst V, Jaafar P, Legendre A, Le Bouffant F, Toquet C, Roy E, McGregor L, Lynch SA, Newbury-Ecob R, Tran V, Young I, Trochu JN, Le Marec H, Schott JJ (2007) Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy. Circulation 115(1):40–49. doi:10.1161/CIRCULATIONAHA.106.622621
30. Lemmon MA, Schlessinger J (2010) Cell signaling by receptor tyrosine kinases. Cell 141(7):1117–1134. doi:10.1016/j.cell.2010.06.011
31. Leung R, Wang Y, Cuddy K, Sun C, Magalhaes J, Grynpas M, Glogauer M (2010) Filamin A regulates monocyte migration through Rho small GTPases during osteoclastogenesis. J Bone Min Res 25(5):1077–1091. doi:10.1359/jbmr.091114
32. Loy CJ, Sim KS, Yong EL (2003) Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions. Proc Natl Acad Sci USA 100(8):4562–4567. doi:10.1073/pnas.0736237100
33. Maurer G, Tarkowski B, Baccarini M (2011) Raf kinases in cancer-roles and therapeutic opportunities. Oncogene 30(32):3477–3488. doi:10.1038/onc.2011.160
34. McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, Stivala F, Libra M, Basecke J, Evangelisti C, Martelli AM, Franklin RA (2007) Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta 1773(8):1263–1284. doi:10.1016/j.bbamcr.2006.10.001
35. Mendelsohn J, Baselga J (2003) Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Oncol 21(14):2787–2799. doi:10.1200/JCO.2003.01.504
36. Nakamura F, Heikkinen O, Pentikainen OT, Osborn TM, Kasza KE, Weitz DA, Kupiainen O, Permi P, Kilpelainen I, Ylanne J, Hartwig JH, Stossel TP (2009) Molecular basis of filamin A-FilGAP interaction and its impairment in congenital disorders associated with filamin A mutations. PLoS ONE 4(3):e4928. doi:10.1371/journal.pone.0004928
37. Nakamura F, Stossel TP, Hartwig JH (2011) The filamins: organizers of cell structure and function. Cell Adh Migr 5(2):160–169
38. Nallapalli RK, Ibrahim MX, Zhou AX, Bandaru S, Sunkara SN, Redfors B, Pazooki D, Zhang Y, Boren J, Cao Y, Bergo MO, Akyurek LM (2012) Targeting filamin A reduces K-RAS-induced lung adenocarcinomas and endothelial response to tumor growth in mice. Mol Cancer 11:50. doi:10.1186/1476-4598-11-50
39. Neuzillet C, Tijeras-Raballand A, de Mestier L, Cros J, Faivre S, Raymond E (2014) MEK in cancer and cancer therapy. Pharmacol Ther 141(2):160–171. doi:10.1016/j.pharmthera.2013.10.001
40. Ravid D, Chuderland D, Landsman L, Lavie Y, Reich R, Liscovitch M (2008) Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration. Exp Cell Res 314(15):2762–2773. doi:10.1016/j.yexcr.2008.06.004
41. Razinia Z, Makela T, Ylanne J, Calderwood DA (2012) Filamins in mechanosensing and signaling. Ann Rev Biophys 41:227–246. doi:10.1146/annurev-biophys-050511-102252
42. Roepstorff K, Grovdal L, Grandal M, Lerdrup M, van Deurs B (2008) Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer. Histochem Cell Biol 129(5):563–578. doi:10.1007/s00418-008-0401-3
43. Savoy RM, Ghosh PM (2013) The dual role of filamin A in cancer: can’t live with (too much of) it, can’t live without it. Endocr-Related Cancer 20(6):R341–R356. doi:10.1530/ERC-13-0364
44. Wang Y, Kreisberg JI, Bedolla RG, Mikhailova M, de Vere White RW, Ghosh PM (2007) A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells. Oncogene 26(41):6061–6070. doi:10.1038/sj.onc.1210435
45. Wickstead B, Gull K (2011) The evolution of the cytoskeleton. J Cell Biol 194(4):513–525. doi:10.1083/jcb.201102065
46. Yarden Y, Pines G (2012) The ERBB network: at last, cancer therapy meets systems biology. Nat Rev Cancer 12(8):553–563. doi:10.1038/nrc3309
47. Yewale C, Baradia D, Vhora I, Patil S, Misra A (2013) Epidermal growth factor receptor targeting in cancer: a review of trends and strategies. Biomaterials 34(34):8690–8707. doi:10.1016/j.biomaterials.2013.07.100
48. Zhou AX, Hartwig JH, Akyurek LM (2010) Filamins in cell signaling, transcription and organ development. Trends Cell Biol 20(2):113–123. doi:10.1016/j.tcb.2009.12.001
49. Zhu TN, He HJ, Kole S, D’Souza T, Agarwal R, Morin PJ, Bernier M (2007) Filamin A-mediated down-regulation of the exchange factor Ras-GRF1 correlates with decreased matrix metalloproteinase-9 expression in human melanoma cells. J Biol Chem 282(20):14816–14826. doi:10.1074/jbc.M611430200